Agenda Set for September 23 Patent Law and Pharmaceuticals Symposium at Rutgers–Newark Law School

Lunch, Opening Remarks, and Keynote Address, Noon - 1:15 pm
The Hon. Pauline Newman, U.S. Court of Appeals for the Federal Circuit

“An Examination of the Proposed Local Patent Rules for the District of New Jersey,” 1:30 - 2:30 pm

The Hon. Stanley R. Chesler, U.S. District Judge for the District of New Jersey

Edward R. Reines, Esq., Partner, Weil, Gotshal & Manges LLP

Robert G. Shepherd, Esq., Managing Partner, Mathews, Shepherd, McKay & Bruneau, P.A., moderator

“Do Patent Settlements Between Brand Name Companies and Their Generic Rivals Violate the Antitrust Laws? An Exploration of Recent Trends and Legal Developments,” 2:45 - 4:00 pm

Daniel A. Crane, Associate Professor of Law, Cardozo School of Law

C. Scott Hemphill, Associate Professor of Law, Columbia Law School

Keith Sharfman, Professor of Law, Marquette Law School

Sabrina Safrin, Professor of Law, Rutgers School of Law–Newark, moderator

“Views From Industry: Senior In-House Counsel Discuss the Patent Issues That Matter Most to Pharma,” 4:15 - 5:30 pm
Henry Hadad, Vice President & Associate General Counsel, Intellectual Property, Schering-Plough Corporation
David Manspeizer, Vice President Intellectual Property and Associate General Counsel, Wyeth
Jeffrey N. Myers, Ph.D., Vice President and Assistant General Counsel, Intellectual Property Enforcement, Pfizer Inc.
Nicholas Groombridge, Adjunct Professor, Rutgers School of Law–Newark, moderator

Reception, 5:30 pm